EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent Advances in Atomic-Resolution NMR Investigations of Monoclonal Antibodies

Béatrice Vibert iD, Faustine Henot, Oriane Frances, Jérôme Boisbouvier iD

Biomolecules · 08.06.2026 · 16 (6) · 840

DOI: 10.3390/biom16060840 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 08.06.2026. Verfasst von Béatrice Vibert und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institut de Biologie Structurale (IBS), Université Grenoble Alpes, CNRS, CEA, 38044 Grenoble, France. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Nuclear Magnetic Resonance, Biomolecular. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de la Recherche, French National Research Agency, ANRT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Monoclonal antibodies (mAbs) have been the subject of extensive study in recent years due to their recognition as highly promising therapeutic molecules offering high specificity and a low risk of side effects. Monitoring the structure of these molecules is crucial for developing new therapeutics, characterizing interactions with antigens or receptors, and explaining potential changes in activity between antibody production batches. However, commonly used biophysical approaches provide only low-spatial-resolution information, and conventional structural biology techniques such as crystallography and cryo-electron microscopy (cryo-EM) are difficult to apply to these highly dynamic proteins. Solution nuclear magnetic resonance (NMR) spectroscopy is the method of choice for structural studies of flexible proteins at atomic resolution; however, it has traditionally been limited to low-molecular-weight biological systems. In this review, we present recent advances in NMR spectroscopy and advanced isotopic labeling methods that have enabled the atomic-resolution study of both the crystallizable (Fc) and antigen-binding (Fab) fragments of antibodies. We show how NMR is becoming a powerful tool for investigating full-length mAbs at an atomic level, opening up new possibilities for the characterization and in-depth quality control of therapeutic antibodies in solution.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalNuclear Magnetic Resonance, BiomolecularHumansImmunoglobulin Fab FragmentsAnimalsMagnetic Resonance SpectroscopyProtein Conformation

Stichwörter der Autor:innen

FabFcHOSNMRfingerprintsisotopic labelingmAbsmethyl groupsresonance assignment

Substanzen

Antibodies, MonoclonalImmunoglobulin Fab Fragments

Autor:innen und Institutionen

  • Institut de Biologie Structurale (IBS), Université Grenoble Alpes, CNRS, CEA, 38044 Grenoble, France.
  • Integrated Drug Discovery Department, Sanofi R&D, 94400 Vitry-sur-Seine, France.

ORCID-Profile: Béatrice Vibert, Jérôme Boisbouvier

Förderung

  • Agence Nationale de la Recherche
  • French National Research Agency
  • ANRT
  • Sanofi

Zitieren

APA

Vibert, B., Henot, F., Frances, O., & Boisbouvier, J. (2026). Recent Advances in Atomic-Resolution NMR Investigations of Monoclonal Antibodies. Biomolecules, 16(6), 840. https://doi.org/10.3390/biom16060840

Vancouver

Vibert B, Henot F, Frances O, Boisbouvier J. Recent Advances in Atomic-Resolution NMR Investigations of Monoclonal Antibodies. Biomolecules. 2026;16(6):840. doi:10.3390/biom16060840

BibTeX
@article{Vibert2026,
  author = {Vibert, Béatrice and Henot, Faustine and Frances, Oriane and Boisbouvier, Jérôme},
  title = {Recent Advances in Atomic-Resolution NMR Investigations of Monoclonal Antibodies},
  journal = {Biomolecules},
  year = {2026},
  volume = {16},
  number = {6},
  pages = {840},
  doi = {10.3390/biom16060840}
}
Kostenlos starten →